The global multiple myeloma treatment market is experiencing a period of remarkable growth. This growth can be attributed to a number of factors, including an aging population, rising incidence rates of the condition, and developments in treatment options. Key stakeholders in this market are concentrated on developing novel therapies to optimize pa